Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2023-01-06 Director's Dealing
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
111年12月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, senior management, and related parties. It includes specific data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a report publication or announcement, nor is it a transcript or presentation. The document is not a general regulatory filing or a report on legal proceedings. Given the detailed insider shareholding data, this fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification.
2023-01-06 Chinese
111年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and pledges rather than a financial report, earnings release, or management discussion. There is no indication of a meeting, voting results, or legal proceedings. The document is not a report publication announcement as it contains substantive data. This type of document fits best under 'Director's Dealing' (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is about 3,000 characters, consistent with a detailed insider shareholding report rather than a full financial report or announcement.
2023-01-06 Chinese
補充111/11/08公告本公司董事會決議購置不動產 (正式簽約交易資訊)
Capital/Financing Update Classification · 95% confidence The document is a disclosure from a listed company (1762 中化生) about a board resolution to purchase real estate, including detailed transaction information such as property location, price, payment terms, and related party status. It is a specific announcement of a capital asset acquisition transaction, not a full financial report or earnings release. The document length is short (2192 characters) and it provides detailed transaction data rather than referencing or attaching a report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including significant asset acquisitions.
2022-12-23 Chinese
111年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 中化生, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (602 characters) and consists mainly of tabular data about financial guarantees and loans, without any detailed financial statements or analysis. There is no indication of a full report such as an Annual Report (10-K) or Interim Report (IR). It is also not a certification or legal proceeding. The document appears to be a regulatory disclosure or compliance filing related to financial guarantees and loans, typical of a Regulatory Filing (RNS).
2022-12-08 Chinese
111年11月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains financial data for a specific month and year (民國111年11月, which corresponds to November 2022) and compares it to the previous year. The document is short (774 characters) and appears to be a periodic financial summary rather than a full comprehensive report. It does not contain detailed financial statements or extensive analysis typical of an Interim/Quarterly Report (IR) but provides substantive financial data and analysis for a specific period. Therefore, it fits best as an Interim / Quarterly Report (IR).
2022-12-08 Chinese
111年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, chairman, general manager, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, with no financial statements, earnings data, or management discussion. There is no indication of an annual report, earnings release, or other financial report. The document is not a report publication announcement or certification. The detailed insider shareholding data aligns with the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the document is best classified as a Director's Dealing (DIRS) filing.
2022-12-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.